News

Video

OPC 2025: What Pharmacists Love Most About Oncology Pharmacists Connect

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacy experts share the benefits of the annual Oncology Pharmacists Connect meeting.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacy Times OPC
Related Content
Health care professional with cannabis, CBD oil -- Image credit: Elroi | stock.adobe.com
June 25th 2025

Real-World Data Suggests Cannabis Use is Associated With Major Adverse Cardiovascular Events

Gillian McGovern, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
ASCO 2025: Novel Bispecific T-Cell Engager Targeting DLL3 Offers Hope for Refractory Neuroendocrine Carcinomas
June 25th 2025

ASCO 2025: Novel Bispecific T-Cell Engager Targeting DLL3 Offers Hope for Refractory Neuroendocrine Carcinomas

Jaume Capdevila, MD, PhD Alana Hippensteele, Lead Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Hand holding Ozempic Insulin injection pen for diabetics - Image credit: Natalia | stock.adobe.com
June 24th 2025

ADA 2025: Combination of Bimagrumab and Semaglutide Shows Enhanced Fat Loss and Muscle Preservation

Kennedy Ferruggia, Assistant Editor
[AI Generated] 3D Medical Cross-Section of Diabetic Vascular Disease - Microvascular Damage Mechanism
June 24th 2025

Cholesterol-Lowering Drugs May Significantly Increase Risk of Diabetic Microvascular Complications

Luke Halpern, Assistant Editor